用于诊断阿尔茨海默病性痴呆及其他痴呆症的神经心理学测试：横断面研究和延迟验证研究的通用方案
Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies.
作者信息
Davis Daniel Hj, Creavin Sam T, Noel-Storr Anna, Quinn Terry J, Smailagic Nadja, Hyde Chris, Brayne Carol, McShane Rupert, Cullum Sarah
机构信息
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
School of Social and Community Medicine, University of Bristol, Bristol, UK.
出版信息
Cochrane Database Syst Rev. 2013 Mar 28(3). doi: 10.1002/14651858.CD010460.
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the cross-sectional diagnostic accuracy of [index test] at various thresholds for ADD and other dementias [target condition] in [target population].ORTo determine the accuracy of [index test] at various thresholds for diagnosing ADD and other dementias [target condition] in [target population] after a follow-up period (delayed-verification studies).To investigate the heterogeneity of test accuracy in the included studies.To highlight the quality and quantity of research evidence available on the effectiveness of the index test in the target population.To identify gaps in the evidence and determine where further research is required.
摘要
这是一项综述的方案，没有摘要。目标如下：确定[索引测试]在[目标人群]中针对ADD及其他痴呆症[目标疾病]的不同阈值下的横断面诊断准确性。或确定在随访期后（延迟验证研究），[索引测试]在[目标人群]中针对ADD及其他痴呆症[目标疾病]的不同阈值下的诊断准确性。调查纳入研究中测试准确性的异质性。强调关于索引测试在目标人群中的有效性的现有研究证据的质量和数量。识别证据中的差距并确定需要进一步研究的方向。
相似文献
1
Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies.
Cochrane Database Syst Rev. 2013 Mar 28(3). doi: 10.1002/14651858.CD010460.
2
Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.
Cochrane Database Syst Rev. 2019 Sep 14;9(9):CD011414. doi: 10.1002/14651858.CD011414.pub2.
3
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
4
Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting.
Cochrane Database Syst Rev. 2015 Feb 3(2):CD010860. doi: 10.1002/14651858.CD010860.pub2.
5
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
8
18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012883. doi: 10.1002/14651858.CD012883.
9
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
10
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
引用本文的文献
1
Diagnostic test accuracy of self-administered cognitive assessment tools for dementia.
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD013725. doi: 10.1002/14651858.CD013725.pub2.
2
Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus.
Caspian J Intern Med. 2024 Winter;15(1):58-65. doi: 10.22088/cjim.15.1.6.
3
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings.
Cochrane Database Syst Rev. 2023 Nov 21;11(11):CD013126. doi: 10.1002/14651858.CD013126.pub2.
4
New horizons in evidence synthesis for older adults.
Age Ageing. 2023 Nov 2;52(11). doi: 10.1093/ageing/afad211.
5
Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults.
Healthcare (Basel). 2022 May 13;10(5):906. doi: 10.3390/healthcare10050906.
6
Cognitive screening instruments for dementia: comparing metrics of test limitation.
Dement Neuropsychol. 2021 Oct-Dec;15(4):458-463. doi: 10.1590/1980-57642021dn15-040005.
7
Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia.
Cochrane Database Syst Rev. 2022 Apr 8;4(4):CD013724. doi: 10.1002/14651858.CD013724.pub2.
8
European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.
Eur Stroke J. 2021 Sep;6(3):I-XXXVIII. doi: 10.1177/23969873211042192. Epub 2021 Oct 8.
9
Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2021 Jul 27;7(7):CD010783. doi: 10.1002/14651858.CD010783.pub3.
10
Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment.
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013786. doi: 10.1002/14651858.CD013786.pub2.
本文引用的文献
1
Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation.
Res Synth Methods. 2012 Sep;3(3):202-13. doi: 10.1002/jrsm.1046. Epub 2012 Jun 14.
2
A systematic review of the accuracy and clinical utility of the Addenbrooke's Cognitive Examination and the Addenbrooke's Cognitive Examination-Revised in the diagnosis of dementia.
Int J Geriatr Psychiatry. 2012 Jul;27(7):659-69. doi: 10.1002/gps.2771. Epub 2011 Nov 8.
3
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
Ann Intern Med. 2011 Oct 18;155(8):529-36. doi: 10.7326/0003-4819-155-8-201110180-00009.
4
UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
Eur J Neurol. 2012 Jan;19(1):149-54. doi: 10.1111/j.1468-1331.2011.03500.x. Epub 2011 Sep 24.
5
How golden is the gold standard of neuropathology in dementia?
Alzheimers Dement. 2011 Jul;7(4):486-9. doi: 10.1016/j.jalz.2011.04.011.
6
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
7
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21.
8
Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies.
J Clin Epidemiol. 2011 Jun;64(6):602-7. doi: 10.1016/j.jclinepi.2010.07.006. Epub 2010 Nov 13.
9
Why are we copyrighting science?
BMJ. 2010 Sep 16;341:c4738. doi: 10.1136/bmj.c4738.
10
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study.
PLoS Med. 2009 Nov;6(11):e1000180. doi: 10.1371/journal.pmed.1000180. Epub 2009 Nov 10.
Zotero 插件